SCHEMBL958960

SCHEMBL958960

O=C(NCc1cccs1)c1n[nH]c2ccccc12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.64
MAPK10 P53779 1/20 0.64
HSD17B10 Q99714 1/20 0.64
NPC1 O15118 4/20 0.57
GAA P10253 3/20 0.57
ALDH1A1 P00352 2/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
SMN1; SMN2 Q16637 6/20 0.56
RAB9A P51151 5/20 0.56
HTT P42858 1/20 0.56
HPGD P15428 3/20 0.55
YTHDC1 Q96MU7 1/20 0.55
POLB P06746 1/20 0.53
CCNA2 P20248 1/20 0.52
CDK2 P24941 1/20 0.52
FLT3 P36888 1/20 0.52
CCNA1 P78396 1/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
SIRT1 Q96EB6 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL952028 0.81 SMN1; SMN2 (0.77) KDM4EMAPK10HSD17B10NPC1GAA
SCHEMBL952273 0.80 KDM4E (0.68) KDM4EMAPK10HSD17B10NPC1GAA
SCHEMBL4311166 0.79 HPGD (0.50) KDM4EHSD17B10NPC1GAAALDH1A1
SCHEMBL4311170 0.79 HPGD (0.50) KDM4EHSD17B10NPC1GAAALDH1A1
SCHEMBL954391 0.78 KDM4E (1.00) KDM4EMAPK10HSD17B10NPC1GAA
SCHEMBL20267080 0.77 RAB9A (0.75) KDM4EMAPK10HSD17B10NPC1GAA
SCHEMBL8373049 0.76 SMN1; SMN2 (0.63) KDM4EMAPK10HSD17B10NPC1GAA
SCHEMBL951202 0.76 FLT3 (0.67) KDM4EMAPK10HSD17B10NPC1GAA
SCHEMBL950894 0.75 NPC1 (0.68) KDM4EMAPK10HSD17B10NPC1GAA
SCHEMBL13373682 0.75 LMNA (0.50) ALDH1A1SMN1; SMN2RAB9AHTTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110015234-A1 INDAZOLE DERIVATIVES ACKERMANN JEAN 2011-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110015234-A1 INDAZOLE DERIVATIVES CPT1A, CPT1B, CES1 KDM4E 2887/4885MAPK10 4455/4885HSD17B10 183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.